DiamiR's Grant - II Round

DiamiR raised a round of funding on March 16, 2015. Investors include National Institutes of Health.

DiamiR is a privately held molecular diagnostic company focused on developing noninvasive tests for early detection and monitoring of Mild Cognitive Impairment, Alzheimer's disease, other neurodegener…

Articles about DiamiR's Grant - II Round: